..Even as the race to develop a safe vaccine for the novel coronavirus infection intensifies across the world, Bharat Biotech International Ltd (BBIL) and the Indian Council for Medical Research (ICMR) have partnered to develop an indigenous COVID-19 vaccine.
The Indian biotechnology firm has already started testing a unique coronavirus vaccine called ‘CoroFlu’, a one-drop COVID-19 nasal vaccine built on the backbone of a flu vaccine proven to be safe in humans, as part of its international collaboration with the University of Wisconsin, Madison, and the vaccine companies FluGen.
Talking about the company’s notable project with the ICMR and National Institute of Virology (NIV), Pune, Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech, said that the firm would do everything make the program successful...
Full text at GMPnews.Net